BioSpace News Archive

BioMidwest

Northwestern Medicine’s Clinical Trial Targets Devastating Heart Failure Diagnosis

Lynne Austin found she was increasingly out of breath doing even the simplest of tasks as 2015 came to a close.

November 6, 2017

·

4 min read

FDA

Abbott’s MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan

The MitraClip system is a catheter-based, minimally-invasive therapy that is delivered to the heart through a blood vessel in the leg.

November 6, 2017

·

4 min read

Drug Development

Themis to Present Phase II Interim Results for Chikungunya Vaccine Candidate at ASTMH 2017 Annual Meeting

The data will be presented today for the first time at the Annual Meeting of the ASTMH in Baltimore, MA, USA.

November 6, 2017

·

2 min read

Business

Strongbridge Biopharma plc to Host Third Quarter 2017 Financial Results Conference Call on November 14, 2017

The conference call will follow the anticipated release of the Company’s financial results earlier that day.

November 6, 2017

·

2 min read

Pharm Country

QuintilesIMS is now IQVIA

Beginning on November 15, 2017, equity shares of the company will trade on the NYSE under the new name and new ticker symbol “IQV.”

November 6, 2017

·

3 min read

Business

Minerva Neurosciences Reports Third Quarter 2017 Financial Results and Business Updates

Cash, cash equivalents and marketable securities as of September 30, 2017 were approximately $143.3 million, compared to $83.0 million as of December 31, 2016.

November 6, 2017

·

9 min read

Business

Avinger Enters Into Common Stock Purchase Agreement for up to $15M With Lincoln Park Capital

The Company is filing a registration statement with the SEC relating to the transaction.

November 6, 2017

·

4 min read

Business

Thermo Fisher Scientific and Cellular Biomedicine Group Announce Strategic Partnership to Develop Manufacturing Processes

The partnership focuses on the research and development of an automated cell therapy manufacturing system.

November 6, 2017

·

6 min read

Business

Myriad Genetics Collaborates With CareFirst BlueCross BlueShield on Coverage with Evidence Development (CED) Study for the Vectra DA Test

Vectra DA is a pioneering test designed to predict whether patients with RA are at risk for radiographic progression (RP) so that rheumatologists can optimize treatment decisions.

November 6, 2017

·

8 min read

Business

Heron Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2017 and Recent Corporate Progress

Net product sales of SUSTOL for the three months ended September 30, 2017 were $8.6 million and totaled $20.7 million for the nine months ended September 30, 2017.

November 6, 2017

·

6 min read